BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy
FDA 503B outsourcing facility
Temple Terrace, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2019
- Sterile compounding from bulk substances: No
- Last FDA inspection: March 12, 2026
- FDA action: FMD-145 Letter Issued 9/18/2023
- 3 FDA drug recalls on record (2021 to 2022)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- June 4, 2019
- Most recent registration
- February 5, 2026
- Compounds sterile drugs from bulk substances
- No
- Last FDA inspection
- March 12, 2026
The FDA last inspected BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy on March 12, 2026. Investigators issued a Form FDA 483 listing inspectional observations at that visit. FDA action on record: FMD-145 Letter Issued 9/18/2023.
FDA recall history
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy has 3 FDA drug recalls on record between 2021 and 2022, based on the FDA enforcement database. Breakdown: 1 Class I, 1 Class II, 1 Class III.
Recall reasons on record include labeling: label error on declared strength: syringes mislabeled as 300 mg iodine/ml; subpotent drug; lack of sterility assurance.
| Date | Class | Product | Reason |
|---|---|---|---|
| December 2022 | Class I | Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packaged in a bag labeled as Omnipaque ( | Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL |
| February 2022 | Class III | Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple T | Subpotent drug |
| July 2021 | Class II | Succinylcholine Chloride 100 mg/5 mL (20 mg/mL), 5 mL Syringes, Rx only, For IV Use only, BayCare Central Pharmacy, 7802 E. Telecom Parkway, | Lack of sterility assurance |
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
Compounded peptides and GLP-1s
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
7802 E Telecom Pkwy, N/A, Temple Terrace, FL 33637-0928
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Kyle Brauer, 1-813-901-6376. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy registered with the FDA?
Yes. BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy is a registered 503B outsourcing facility, first registered with the FDA on June 4, 2019 and most recently registered on February 5, 2026.
Has BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy been inspected by the FDA?
The FDA last inspected BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy on March 12, 2026. A Form FDA 483 was issued. FDA action on record: FMD-145 Letter Issued 9/18/2023.
Has BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy had any FDA drug recalls?
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy has 3 FDA drug recalls on record (2021 to 2022) in the FDA enforcement database.
What does BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy compound?
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy located?
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy is located in Temple Terrace, Florida (7802 E Telecom Pkwy).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.